22nd Century Group Announces Exercise of Existing Warrants and Fundraising

Business by 2FIRSTS.ai

Dec.05.2023

22nd Century Group Announces Exercise of Existing Warrants and Fundraising

BioTech company 22nd Century Group, Inc. announced the exercise of existing options by shareholders, generating approximately $3.2 million in revenue.

According to a report published by Menafn on December 4th, the biotechnology company 22nd Century Group, Inc. (NASDAQ: XXII), based in Buffalo, New York, announced that some holders plan to exercise their existing stock options as part of the previously disclosed incentive stock option program.

During this exercise period, several existing stock option holders of the company purchased a total of 14,767,386 common shares at a reduced exercise price of $0.215 per share.

Currently, the company has received a total gross income of approximately 3.2 million dollars.

The newly appointed Chairman and CEO, Larry Firestone, has announced that this funding will serve as crucial operational capital to support the company's tobacco business and drive its restructuring efforts to enhance performance in the tobacco industry and reduce operational costs.

References:

[1] 22Nd Century Secures $3.2 Million To Date In Warrant Exchange Transaction

Also Read:

[1] 22nd Century Group Announces Exercise of Existing Warrants and Fundraising

[2] 22nd Century Group Inc's Stock Drops 12.26%, but Shows Recent Recovery

#North America #United States #Traditional tobacco #Personnel announcement #Charity

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months

The U.S. Food and Drug Administration (FDA) has added Cytisinicline, a plant-based therapy developed by Achieve Life Sciences for nicotine vaping addiction, to its new National Priority Voucher (CNPV) program. The initiative shortens drug review timelines from 10–12 months to just 1–2 months, expediting approval for treatments that address major public health needs.

Oct.20 by 2FIRSTS.ai

Heaven Gifts’s HNB Brand REJO Launches New Device with Design Strikingly Similar to ELFBAR JOINOne Series

Miracle’s heated tobacco brand REJO has launched its new device REJO CUBE in Dubai. The device’s industrial design is highly similar to the ELFBAR JOINOne series, featuring a left-right magnetic structure and side-mounted screen. Positioning the Middle East as a key market, REJO is moving ahead with local team building and entity setup in the region.

Nov.14 by 2FIRSTS.ai

UK Experts Raise Concerns Over High-Dose Nicotine Pouches Amid Rising Sales

According to The Guardian, health experts in the UK are warning about the potential health effects of high-dose nicotine pouches as their sales continue to rise. Recent studies show teenagers reporting nicotine rushes, sickness and fainting, while researchers say packaging and marketing increasingly appeal to younger age groups. Although viewed as less harmful than cigarettes, experts remain concerned about their use among non-smokers, especially adolescents.

Nov.13 by 2FIRSTS.ai

2Firsts Investigation | China–U.S. E-cigarette Shipping Costs Surge: Sea Freight Up Over 200%, Air Cargo Inspection Rate Exceeds 50%

Since late July, China–U.S. e-cigarette shipping costs have surged — sea freight up over 200%, air cargo inspection rates exceeding 50%. 2Firsts investigates the key drivers behind the spike and how the industry is responding.